13D/13G Filings - Avidity Partners Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-14
12:19 pm
Sale
2022-12-31 13G Viridian Therapeutics, Inc.
VRDN
Avidity Partners Management LP 0
0.000%
-1,278,261decrease
(Position Closed)
Filing
History
2023-02-14
12:02 pm
Purchase
2022-12-31 13G Zentalis Pharmaceuticals, Inc.
ZNTL
Avidity Partners Management LP 5,150,000
9.000%
2,127,210increase
(+70.37%)
Filing
History
2023-02-02
3:15 pm
Purchase
2023-01-25 13G Praxis Precision Medicines, Inc.
PRAX
Avidity Partners Management LP 273,333
8.700%
273,333increase
(New Position)
Filing
History
2022-12-08
10:22 am
Purchase
2022-12-05 13G Karyopharm Therapeutics Inc.
KPTI
Avidity Partners Management LP 756,788
9.900%
756,788increase
(New Position)
Filing
History
2022-10-27
09:56 am
Purchase
2022-10-26 13G ESSA Pharma Inc.
EPIX
Avidity Partners Management LP 3,750,000
8.500%
3,750,000increase
(New Position)
Filing
History
2022-09-20
4:35 pm
Purchase
2022-09-16 13G Syros Pharmaceuticals, Inc.
SYRS
Avidity Partners Management LP 2,120,000
9.900%
2,120,000increase
(New Position)
Filing
History
2022-09-16
10:16 am
Purchase
2022-09-15 13G Akero Therapeutics, Inc.
AKRO
Avidity Partners Management LP 3,105,000
6.900%
3,105,000increase
(New Position)
Filing
History
2022-06-16
4:38 pm
Purchase
2022-06-15 13G Arvinas, Inc.
ARVN
Avidity Partners Management LP 3,239,838
6.100%
3,239,838increase
(New Position)
Filing
History
2022-02-14
09:18 am
Purchase
2021-12-31 13G IDEAYA Biosciences, Inc.
IDYA
Avidity Partners Management LP 2,553,000
6.600%
82,821increase
(+3.35%)
Filing
History
2022-02-11
8:54 pm
Purchase
2021-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
Avidity Partners Management LP 5,244,019
9.900%
494,019increase
(+10.40%)
Filing
History
2022-02-11
8:39 pm
Purchase
2021-12-31 13G SCYNEXIS, Inc.
SCYX
Avidity Partners Management LP 2,239,278
9.300%
259,478increase
(+13.11%)
Filing
History
2022-02-11
8:34 pm
Purchase
2021-12-31 13G OncoSec Medical Incorporated
ONCS
Avidity Partners Management LP 133,864
7.500%
45,136increase
(+50.87%)
Filing
History
2022-02-11
8:18 pm
Purchase
2021-12-31 13G Alpine Immune Sciences, Inc.
ALPN
Avidity Partners Management LP 2,205,687
7.300%
735,297increase
(+50.01%)
Filing
History
2022-02-11
8:10 pm
Purchase
2021-12-31 13G Viridian Therapeutics, Inc.
VRDN
Avidity Partners Management LP 1,278,261
5.900%
1,278,261increase
(New Position)
Filing
History
2022-02-11
7:52 pm
Purchase
2021-12-31 13G PhaseBio Pharmaceuticals, Inc.
PHASQ
Avidity Partners Management LP 4,405,000
9.200%
120,000increase
(+2.80%)
Filing
History
2022-02-11
7:43 pm
Sale
2021-12-31 13G IVERIC bio, Inc.
ISEE
Avidity Partners Management LP 6,955,000
6.100%
-270,000decrease
(-3.74%)
Filing
History
2022-02-11
7:18 pm
Purchase
2021-12-31 13G GRITSTONE BIO INC
GRTSQ
Avidity Partners Management LP 6,990,194
9.900%
2,443,380increase
(+53.74%)
Filing
History
2022-02-11
7:12 pm
Sale
2021-12-31 13G Cardiff Oncology, Inc.
CRDF
Avidity Partners Management LP 0
0.000%
-2,153,600decrease
(Position Closed)
Filing
History
2022-02-11
6:54 pm
Sale
2021-12-31 13G Anika Therapeutics, Inc.
ANIK
Avidity Partners Management LP 0
0.000%
-731,000decrease
(Position Closed)
Filing
History
2022-02-11
6:31 pm
Purchase
2021-12-31 13G Adicet Bio, Inc.
ACET
Avidity Partners Management LP 3,034,004
7.900%
1,174,004increase
(+63.12%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next